EUVIMEDEUVIMED entdecken
Crossref

Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes

Lesya Yanitska, Oksana Horkunenko, Danylo Yevstifeiev, Roman Syrvatka, Yulianna Kovalenko, Viktoriia Sydorenko, Andrii Karpenko, Tamara Kuchmerovska

Comparative Clinical Pathology · 20.11.2026 · 35 (1)

DOI: 10.1007/s00580-026-03893-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comparative Clinical Pathology, online erschienen am 20.11.2026. Verfasst von Lesya Yanitska und 7 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yanitska, L., Horkunenko, O., Yevstifeiev, D., Syrvatka, R., Kovalenko, Y., Sydorenko, V., Karpenko, A., & Kuchmerovska, T. (2026). Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes. Comparative Clinical Pathology, 35(1). https://doi.org/10.1007/s00580-026-03893-w

Vancouver

Yanitska L, Horkunenko O, Yevstifeiev D, Syrvatka R, Kovalenko Y, Sydorenko V, et al. Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes. Comparative Clinical Pathology. 2026;35(1). doi:10.1007/s00580-026-03893-w

BibTeX
@article{Yanitska2026,
  author = {Yanitska, Lesya and Horkunenko, Oksana and Yevstifeiev, Danylo and Syrvatka, Roman and Kovalenko, Yulianna and Sydorenko, Viktoriia and Karpenko, Andrii and Kuchmerovska, Tamara},
  title = {Evaluating high-dose biotin and insulin therapy in a dose-refined model of streptozotocin-induced type 1 diabetes},
  journal = {Comparative Clinical Pathology},
  year = {2026},
  volume = {35},
  number = {1},
  doi = {10.1007/s00580-026-03893-w}
}
Kostenlos starten →